O'Byrne Jason

O'Byrne Jason is listed in filings as EVP & Chief Financial Officer at Vir Biotechnology, Inc.. This profile follows SEC Form 4 activity through Mar 23, 2026, including sale activity. Recent filings connect the profile to Vir Biotechnology, Inc. (VIR). The current snapshot covers public activity from Nov 18, 2024 to Mar 23, 2026. Reported amounts are shown as $15.6K to $37.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.